BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18243530)

  • 1. BARD1 regulates BRCA1-mediated transactivation of the p21WAF1/CIP1 and Gadd45 promoters.
    Fabbro M; Henderson BR
    Cancer Lett; 2008 May; 263(2):189-96. PubMed ID: 18243530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
    Fabbro M; Schuechner S; Au WW; Henderson BR
    Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
    Hashizume R; Fukuda M; Maeda I; Nishikawa H; Oyake D; Yabuki Y; Ogata H; Ohta T
    J Biol Chem; 2001 May; 276(18):14537-40. PubMed ID: 11278247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
    Hayami R; Sato K; Wu W; Nishikawa T; Hiroi J; Ohtani-Kaneko R; Fukuda M; Ohta T
    Cancer Res; 2005 Jan; 65(1):6-10. PubMed ID: 15665273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
    Dizin E; Irminger-Finger I
    Int J Biochem Cell Biol; 2010 May; 42(5):693-700. PubMed ID: 20060929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BRCA1/BARD1 ubiquitin ligase and its substrates.
    Witus SR; Stewart MD; Klevit RE
    Biochem J; 2021 Sep; 478(18):3467-3483. PubMed ID: 34591954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.
    Wiener D; Gajardo-Meneses P; Ortega-Hernández V; Herrera-Cares C; Díaz S; Fernández W; Cornejo V; Gamboa J; Tapia T; Alvarez C; Carvallo P
    Breast Cancer Res Treat; 2015 Oct; 153(3):669-78. PubMed ID: 26395808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.
    Stewart MD; Zelin E; Dhall A; Walsh T; Upadhyay E; Corn JE; Chatterjee C; King MC; Klevit RE
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):1316-1321. PubMed ID: 29367421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.
    Rodriguez JA; Schüchner S; Au WW; Fabbro M; Henderson BR
    Oncogene; 2004 Mar; 23(10):1809-20. PubMed ID: 14647430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel interaction between HPV E6 and BARD1 (BRCA1-associated ring domain 1) and its biologic roles.
    Yim EK; Lee KH; Myeong J; Tong SY; Um SJ; Park JS
    DNA Cell Biol; 2007 Oct; 26(10):753-61. PubMed ID: 17678435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function.
    Sankaran S; Starita LM; Simons AM; Parvin JD
    Cancer Res; 2006 Apr; 66(8):4100-7. PubMed ID: 16618730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of BARD1 targeting and dynamics at the centrosome: the role of CRM1, BRCA1 and the Q564H mutation.
    Brodie KM; Mok MTS; Henderson BR
    Cell Signal; 2012 Feb; 24(2):451-459. PubMed ID: 21982881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
    Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
    Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.
    Somasundaram K; Zhang H; Zeng YX; Houvras Y; Peng Y; Zhang H; Wu GS; Licht JD; Weber BL; El-Deiry WS
    Nature; 1997 Sep; 389(6647):187-90. PubMed ID: 9296497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs.
    Atipairin A; Canyuk B; Ratanaphan A
    Breast Cancer Res Treat; 2011 Feb; 126(1):203-9. PubMed ID: 20878461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex.
    Kim HS; Li H; Cevher M; Parmelee A; Fonseca D; Kleiman FE; Lee SB
    Cancer Res; 2006 May; 66(9):4561-5. PubMed ID: 16651405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export.
    Fabbro M; Rodriguez JA; Baer R; Henderson BR
    J Biol Chem; 2002 Jun; 277(24):21315-24. PubMed ID: 11925436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCC36 is essential for ionizing radiation-induced BRCA1 phosphorylation and nuclear foci formation.
    Chen X; Arciero CA; Wang C; Broccoli D; Godwin AK
    Cancer Res; 2006 May; 66(10):5039-46. PubMed ID: 16707425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase.
    Sato K; Hayami R; Wu W; Nishikawa T; Nishikawa H; Okuda Y; Ogata H; Fukuda M; Ohta T
    J Biol Chem; 2004 Jul; 279(30):30919-22. PubMed ID: 15184379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage.
    Brodie KM; Henderson BR
    Cell Signal; 2010 Feb; 22(2):291-302. PubMed ID: 19796682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.